247 related articles for article (PubMed ID: 2817847)
1. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Blum RA; Kohli RK; Harrison NJ; Schentag JJ
Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
[TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of intravenous ampicillin plus sulbactam in healthy elderly and young adult subjects.
Rho JP; Jones A; Woo M; Castle S; Smith K; Bawdon RE; Norman DC
J Antimicrob Chemother; 1989 Oct; 24(4):573-80. PubMed ID: 2613605
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
Lorenzen JM; Broll M; Kaever V; Burhenne H; Hafer C; Clajus C; Knitsch W; Burkhardt O; Kielstein JT
Clin J Am Soc Nephrol; 2012 Mar; 7(3):385-90. PubMed ID: 22223613
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of sulbactam/ampicillin in humans after intravenous and intramuscular injection.
Ripa S; Ferrante L; Prenna M
Chemotherapy; 1990; 36(3):185-92. PubMed ID: 2338029
[TBL] [Abstract][Full Text] [Related]
6. Effect of impaired renal function on the pharmacokinetics of coadministered cefoperazone and sulbactam.
Rho JP; Castle S; Smith K; Bawdon RE; Norman DC
J Antimicrob Chemother; 1992 Jun; 29(6):701-9. PubMed ID: 1506350
[TBL] [Abstract][Full Text] [Related]
7. Isepamicin disposition in subjects with various degrees of renal function.
Halstenson CE; Kelloway JS; Affrime MB; Lin CC; Teal MA; Shapiro BE; Awni WM
Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lomefloxacin in renally compromised patients.
Blum RA; Schultz RW; Schentag JJ
Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of ampicillin/sulbactam (2:1) combination after intravenous administration to sheep and goats.
Carceles CM; Espuny A; Vicente MS; Diaz MS; Escudero E
Res Vet Sci; 1996 Sep; 61(2):143-6. PubMed ID: 8880984
[TBL] [Abstract][Full Text] [Related]
10. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Matzke GR; Abraham PA; Halstenson CE; Keane WF
Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T
Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of carumonam in patients with renal insufficiency.
Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
[TBL] [Abstract][Full Text] [Related]
13. Disposition of famotidine in renal insufficiency.
Halstenson CE; Abraham PA; Opsahl JA; Chremos AN; Keane WF; Matzke GR
J Clin Pharmacol; 1987 Oct; 27(10):782-7. PubMed ID: 3429684
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ampicillin-sulbactam in healthy elderly and young volunteers.
Meyers BR; Wilkinson P; Mendelson MH; Walsh S; Bournazos C; Hirschman SZ
Antimicrob Agents Chemother; 1991 Oct; 35(10):2098-101. PubMed ID: 1759832
[TBL] [Abstract][Full Text] [Related]
15. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
Majcher-Peszynska J; Loebermann M; Klammt S; Frimmel S; Mundkowski RG; Welte T; Reisinger EC; Drewelow B;
Infection; 2014 Feb; 42(1):79-87. PubMed ID: 23904004
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.
Soto E; Shoji S; Muto C; Tomono Y; Marshall S
Br J Clin Pharmacol; 2014 Mar; 77(3):509-21. PubMed ID: 24102758
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.
Wildfeuer A; Schwiersch U; Engel K; von Castell E; Schilling A; Potempa J; Lenders H
Arzneimittelforschung; 1988 Nov; 38(11):1640-3. PubMed ID: 3214451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
